AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vrizid M 80mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Vrinda Life

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Vrizid M 80mg/500mg Tablet SR

Metformin/glimepiride 80mg/500mg extended-release tablets are classified as antidiabetic agents. This dual-medication formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as premature discontinuation can elevate glucose levels, risking complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremor; constipation; and vomiting. Prompt glucose intake (e.g., sugary foods, fruit juice) is crucial for hypoglycemia management. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects comprise altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a possible consequence. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may recommend blood tests to assess blood cell counts and liver function.

Primary Ingredients of Vrizid M 80mg/500mg Tablet SR

No information provided. Therefore, no rephrasing is possible.

Uses of Vrizid M 80mg/500mg Tablet SR

Non-insulin-dependent diabetes

Major Benefits of Vrizid M 80mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vrizid M 80mg/500mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this extended-release tablet with a meal.

Common Side effects of Vrizid M 80mg/500mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Vrizid M 80mg/500mg Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Vrizid M 80mg/500mg Sustained-Release tablets with a meal.

How Vrizid M 80mg/500mg Tablet SR works:

Each Vrizid M 80mg/500mg extended-release tablet combines gliclazide and metformin, both medications used to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vrizid M 80mg/500mg SR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Vrizid M 80mg/500mg SR tablets is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Vrizid M 80mg/500mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when administering Vrizid M 80mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Vrizid M 80mg/500mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Vrizid M 80mg/500mg SR tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate treatment with a reduced Vrizid M 80mg/500mg SR tablet dosage; its use is contraindicated in cases of severe liver disease.

What if you forget to take Vrizid M 80mg/500mg Tablet SR :

Should you forget to take a Vrizid M 80mg/500mg Tablet SR, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vrizid M 80mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vrizid M 80mg/500mg Tablet SR

Vrizid M 80mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Vrizid M 80mg/500mg Tablet SR may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Vrizid M 80mg/500mg Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Vrizid M 80mg/500mg Tablet SR can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is avoided in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Vrizid M and seek immediate medical attention.
Prolonged Vrizid M 80mg/500mg Tablet SR use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Patients with known allergies to Vrizid M 80mg/500mg Tablet SR components or excipients, or those with moderate-to-severe kidney disease or metabolic acidosis (including diabetic ketoacidosis), should not use this medication.
Combining Vrizid M 80mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Vrizid M 80mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Vrizid M 80mg/500mg SR tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Vrizid M 80mg/500mg Tablet SR can cause low blood sugar (hypoglycemia), resulting in symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases if you skip meals, drink alcohol, overexert yourself, or use other diabetes medications concurrently. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Vrizid M 80mg/500mg Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is avoided in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Vrizid M 80mg/500mg Tablet SR and seek immediate medical attention.
Prolonged use of Vrizid M 80mg/500mg Tablet SR can lead to vitamin B12 deficiency by interfering with its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Vrizid M 80mg/500mg Tablet SR is contraindicated in patients with allergies to its components or excipients, and in those with moderate-to-severe kidney disease or metabolic acidosis, such as diabetic ketoacidosis.
Combining Vrizid M 80mg/500mg SR tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Vrizid M 80mg/500mg Table...
44
MRP 50
12% off